RHYTHM PHARMACEUTICALS, INC. (RYTM)
SEC filings, insider trading & institutional ownership from EDGAR.
Institutions
42
$4.35B held
Latest filings
10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR
No filings are available yet.
Top holders
13F & 13D/G · latest quarter
| Holder | Filed | Value |
|---|---|---|
| BlackRock, Inc. | Aug 7, 2026 | $683.60M |
| PRIMECAP MANAGEMENT CO/CA/ | Aug 14, 2026 | $351.84M |
| Vanguard Portfolio Management | Aug 13, 2026 | $348.29M |
| Vanguard Capital Management | Aug 13, 2026 | $333.75M |
| JPMORGAN CHASE & CO | Aug 12, 2026 | $292.18M |
RYTM's filings are public. The insight is one click away.
Scrutar's AI reads every RYTM filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.
Red Flag Detection20+ forensic checks per filingRisk RadarYear-over-year changes in risk factorsFiling DNADisclosure quality scored across six dimensionsSupply Chain GraphCustomers, suppliers & competitors mapped
Analyze RYTM filingsNo credit cardAI reports included on the free plan
Never miss a RYTM filing.
Get an email when RYTM files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Data as of Aug 29, 2026Source: SEC EDGAR.